 | | DRUG: Empagliflozin, linagliptin and metformin hydrochloride | |
Entry |
|
Name |
Empagliflozin, linagliptin and metformin hydrochloride; Trijardy xr (TN) |
Product |
|
Component |
|
Class |
Antidiabetic agent
DG02044 Hypoglycemic agent
DG03228 Combination of metformin, DPP-4 inhibitor and SGLT2 inhibitor
|
Remark |
|
Efficacy |
Antidiabetic |
Disease |
Type 2 diabetes mellitus [DS: H00409] |
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BD Combinations of oral blood glucose lowering drugs
A10BD27 Metformin, linagliptin and empagliflozin
D11856 Empagliflozin, linagliptin and metformin hydrochloride <US>
USP drug classification [BR:br08302]
Blood Glucose Regulators
Antidiabetic Combinations
Empagliflozin/ Linagliptin/ Metformin Hydrochloride
D11856 Empagliflozin, linagliptin and metformin hydrochloride
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG03228 Combination of metformin, DPP-4 inhibitor and SGLT2 inhibitor
D11856 Empagliflozin, linagliptin and metformin hydrochloride
Drug classes [BR:br08332]
Antidiabetic agent
DG02044 Hypoglycemic agent
D11856 Empagliflozin, linagliptin and metformin hydrochloride
|
Other DBs |
|
LinkDB |
|
|
» Japanese version » Back
|